The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- Finding freedom as a physician through entrepreneurship (American Medical Association)
- Regulatory burdens continue to mount for physician practices (Fierce Healthcare)
- The unconventional players in the physician acquisition game (Becker’s ASC Review)
- Why Gastroenterology Is One of the Most In-Demand Locums Specialties (Hayes Locums)
- Snailing colorectal cancer drug delivery, once and for all (BioTechniques)
- Goodbye colonoscopy? New stool test detects 90% of colorectal cancers (Science Daily)
- CBT for IBS: A Frontline Treatment, Not Adjunct Therapy (Gastroenterology Advisor)
- Clinical practice update: Electrosurgery guidance refines endoscopy practice (GI & Hepatology News)
